Virpax Pharmaceuticals (VRPX) Misses Q2 EPS by 175c
Tweet
Share
E-mailGet Alerts VRPX Hot Sheet
Join SI Premium – FREE
Virpax Pharmaceuticals (NASDAQ: VRPX) reported Q2 EPS of ($1.75).
For earnings history and earnings-related data on Virpax Pharmaceuticals (VRPX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- BetterLife Pharma files final prospectus for $100M public offering
- Trilogy Metals closes $35.6M investment from U.S. Department of War
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
